nodes	percent_of_prediction	percent_of_DWPC	metapath
Paliperidone—DRD4—conduct disorder	0.611	0.684	CbGaD
Paliperidone—HTR2A—conduct disorder	0.282	0.316	CbGaD
Paliperidone—Risperidone—DRD4—conduct disorder	0.00271	0.353	CrCbGaD
Paliperidone—Iloperidone—DRD4—conduct disorder	0.00254	0.331	CrCbGaD
Paliperidone—Risperidone—HTR2A—conduct disorder	0.00125	0.163	CrCbGaD
Paliperidone—Iloperidone—HTR2A—conduct disorder	0.00117	0.153	CrCbGaD
Paliperidone—DRD1—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00013	0.0013	CbGpPWpGaD
Paliperidone—DRD1—GPCR ligand binding—DRD4—conduct disorder	0.00013	0.0013	CbGpPWpGaD
Paliperidone—DRD3—GPCR downstream signaling—CGA—conduct disorder	0.00013	0.0013	CbGpPWpGaD
Paliperidone—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000129	0.00129	CbGpPWpGaD
Paliperidone—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.000129	0.00129	CbGpPWpGaD
Paliperidone—HTR1D—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000129	0.00129	CbGpPWpGaD
Paliperidone—DRD3—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000129	0.00128	CbGpPWpGaD
Paliperidone—DRD3—GPCR ligand binding—DRD4—conduct disorder	0.000129	0.00128	CbGpPWpGaD
Paliperidone—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000127	0.00127	CbGpPWpGaD
Paliperidone—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000127	0.00127	CbGpPWpGaD
Paliperidone—HTR1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000126	0.00126	CbGpPWpGaD
Paliperidone—HRH1—G alpha (q) signalling events—HTR2A—conduct disorder	0.000125	0.00125	CbGpPWpGaD
Paliperidone—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000125	0.00124	CbGpPWpGaD
Paliperidone—DRD4—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000124	0.00124	CbGpPWpGaD
Paliperidone—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.000124	0.00123	CbGpPWpGaD
Paliperidone—ADRA1A—G alpha (q) signalling events—HTR2A—conduct disorder	0.000123	0.00123	CbGpPWpGaD
Paliperidone—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00012	0.0012	CbGpPWpGaD
Paliperidone—DRD1—Signaling by GPCR—CGA—conduct disorder	0.00012	0.00119	CbGpPWpGaD
Paliperidone—DRD3—Signaling by GPCR—CGA—conduct disorder	0.000118	0.00118	CbGpPWpGaD
Paliperidone—ADRA2B—GPCR downstream signaling—CGA—conduct disorder	0.000117	0.00117	CbGpPWpGaD
Paliperidone—ADRA2B—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000116	0.00116	CbGpPWpGaD
Paliperidone—ADRA2B—GPCR ligand binding—DRD4—conduct disorder	0.000116	0.00116	CbGpPWpGaD
Paliperidone—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000116	0.00116	CbGpPWpGaD
Paliperidone—HTR1A—GPCR downstream signaling—CGA—conduct disorder	0.000113	0.00113	CbGpPWpGaD
Paliperidone—HTR2C—GPCR downstream signaling—CGA—conduct disorder	0.000113	0.00112	CbGpPWpGaD
Paliperidone—HTR1A—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000112	0.00112	CbGpPWpGaD
Paliperidone—HTR1A—GPCR ligand binding—DRD4—conduct disorder	0.000112	0.00112	CbGpPWpGaD
Paliperidone—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.000112	0.00112	CbGpPWpGaD
Paliperidone—DRD1—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000112	0.00112	CbGpPWpGaD
Paliperidone—HTR2C—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000112	0.00111	CbGpPWpGaD
Paliperidone—HTR2C—GPCR ligand binding—DRD4—conduct disorder	0.000112	0.00111	CbGpPWpGaD
Paliperidone—DRD3—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00011	0.0011	CbGpPWpGaD
Paliperidone—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.00011	0.0011	CbGpPWpGaD
Paliperidone—ADRA2C—GPCR downstream signaling—CGA—conduct disorder	0.00011	0.00109	CbGpPWpGaD
Paliperidone—ADRA2C—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000109	0.00108	CbGpPWpGaD
Paliperidone—ADRA2C—GPCR ligand binding—DRD4—conduct disorder	0.000109	0.00108	CbGpPWpGaD
Paliperidone—ADRA1B—GPCR downstream signaling—CGA—conduct disorder	0.000108	0.00108	CbGpPWpGaD
Paliperidone—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000107	0.00107	CbGpPWpGaD
Paliperidone—ADRA1B—GPCR ligand binding—DRD4—conduct disorder	0.000107	0.00107	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling by GPCR—CGA—conduct disorder	0.000106	0.00106	CbGpPWpGaD
Paliperidone—HTR1A—Signaling by GPCR—CGA—conduct disorder	0.000103	0.00103	CbGpPWpGaD
Paliperidone—HTR2C—Signaling by GPCR—CGA—conduct disorder	0.000102	0.00102	CbGpPWpGaD
Paliperidone—ADRA2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	9.96e-05	0.000994	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling by GPCR—CGA—conduct disorder	9.95e-05	0.000993	CbGpPWpGaD
Paliperidone—DRD2—GPCR downstream signaling—CGA—conduct disorder	9.94e-05	0.000992	CbGpPWpGaD
Paliperidone—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	9.85e-05	0.000983	CbGpPWpGaD
Paliperidone—DRD2—GPCR ligand binding—DRD4—conduct disorder	9.85e-05	0.000983	CbGpPWpGaD
Paliperidone—CYP2D6—Biological oxidations—COMT—conduct disorder	9.82e-05	0.00098	CbGpPWpGaD
Paliperidone—HTR1D—GPCR ligand binding—HTR2A—conduct disorder	9.81e-05	0.000979	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling by GPCR—CGA—conduct disorder	9.79e-05	0.000977	CbGpPWpGaD
Paliperidone—HTR2A—GPCR downstream signaling—CGA—conduct disorder	9.78e-05	0.000976	CbGpPWpGaD
Paliperidone—HRH1—GPCR downstream signaling—CGA—conduct disorder	9.76e-05	0.000974	CbGpPWpGaD
Paliperidone—CYP2D6—Biological oxidations—MAOA—conduct disorder	9.75e-05	0.000973	CbGpPWpGaD
Paliperidone—HTR2A—GPCR ligand binding—DRD4—conduct disorder	9.69e-05	0.000967	CbGpPWpGaD
Paliperidone—CYP2D6—Metapathway biotransformation—COMT—conduct disorder	9.68e-05	0.000967	CbGpPWpGaD
Paliperidone—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	9.67e-05	0.000965	CbGpPWpGaD
Paliperidone—HRH1—GPCR ligand binding—DRD4—conduct disorder	9.67e-05	0.000965	CbGpPWpGaD
Paliperidone—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	9.61e-05	0.000959	CbGpPWpGaD
Paliperidone—HTR1B—GPCR ligand binding—HTR2A—conduct disorder	9.61e-05	0.000959	CbGpPWpGaD
Paliperidone—ADRA1A—GPCR downstream signaling—CGA—conduct disorder	9.58e-05	0.000956	CbGpPWpGaD
Paliperidone—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	9.56e-05	0.000954	CbGpPWpGaD
Paliperidone—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	9.49e-05	0.000947	CbGpPWpGaD
Paliperidone—ADRA1A—GPCR ligand binding—DRD4—conduct disorder	9.49e-05	0.000947	CbGpPWpGaD
Paliperidone—DRD4—GPCR ligand binding—HTR2A—conduct disorder	9.46e-05	0.000944	CbGpPWpGaD
Paliperidone—DRD4—Circadian rythm related genes—EP300—conduct disorder	9.38e-05	0.000936	CbGpPWpGaD
Paliperidone—ADRA2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	9.3e-05	0.000928	CbGpPWpGaD
Paliperidone—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	9.15e-05	0.000914	CbGpPWpGaD
Paliperidone—DRD2—Signaling by GPCR—CGA—conduct disorder	9.03e-05	0.000901	CbGpPWpGaD
Paliperidone—ADRA2A—GPCR downstream signaling—CGA—conduct disorder	8.9e-05	0.000888	CbGpPWpGaD
Paliperidone—HTR1A—SIDS Susceptibility Pathways—EP300—conduct disorder	8.89e-05	0.000887	CbGpPWpGaD
Paliperidone—HTR2A—Signaling by GPCR—CGA—conduct disorder	8.88e-05	0.000886	CbGpPWpGaD
Paliperidone—HRH1—Signaling by GPCR—CGA—conduct disorder	8.86e-05	0.000885	CbGpPWpGaD
Paliperidone—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	8.82e-05	0.00088	CbGpPWpGaD
Paliperidone—ADRA2A—GPCR ligand binding—DRD4—conduct disorder	8.82e-05	0.00088	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling by GPCR—CGA—conduct disorder	8.7e-05	0.000868	CbGpPWpGaD
Paliperidone—DRD1—GPCR ligand binding—HTR2A—conduct disorder	8.51e-05	0.00085	CbGpPWpGaD
Paliperidone—HTR1D—GPCR downstream signaling—DRD4—conduct disorder	8.5e-05	0.000848	CbGpPWpGaD
Paliperidone—DRD1—Circadian rythm related genes—EP300—conduct disorder	8.44e-05	0.000842	CbGpPWpGaD
Paliperidone—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	8.44e-05	0.000842	CbGpPWpGaD
Paliperidone—DRD3—GPCR ligand binding—HTR2A—conduct disorder	8.4e-05	0.000838	CbGpPWpGaD
Paliperidone—DRD3—Circadian rythm related genes—EP300—conduct disorder	8.33e-05	0.000831	CbGpPWpGaD
Paliperidone—HTR1B—GPCR downstream signaling—DRD4—conduct disorder	8.32e-05	0.000831	CbGpPWpGaD
Paliperidone—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	8.29e-05	0.000827	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—CGA—conduct disorder	8.14e-05	0.000813	CbGpPWpGaD
Paliperidone—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	8.13e-05	0.000812	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling by GPCR—CGA—conduct disorder	8.08e-05	0.000807	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—CGA—conduct disorder	7.97e-05	0.000796	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—CGA—conduct disorder	7.85e-05	0.000783	CbGpPWpGaD
Paliperidone—HTR1D—Signaling by GPCR—DRD4—conduct disorder	7.72e-05	0.00077	CbGpPWpGaD
Paliperidone—HTR2A—SIDS Susceptibility Pathways—EP300—conduct disorder	7.68e-05	0.000767	CbGpPWpGaD
Paliperidone—ADRA2B—GPCR ligand binding—HTR2A—conduct disorder	7.58e-05	0.000757	CbGpPWpGaD
Paliperidone—HTR1B—Signaling by GPCR—DRD4—conduct disorder	7.56e-05	0.000754	CbGpPWpGaD
Paliperidone—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	7.55e-05	0.000754	CbGpPWpGaD
Paliperidone—DRD1—GPCR downstream signaling—DRD4—conduct disorder	7.37e-05	0.000736	CbGpPWpGaD
Paliperidone—HTR1A—GPCR ligand binding—HTR2A—conduct disorder	7.32e-05	0.000731	CbGpPWpGaD
Paliperidone—HTR2C—GPCR ligand binding—HTR2A—conduct disorder	7.28e-05	0.000727	CbGpPWpGaD
Paliperidone—DRD3—GPCR downstream signaling—DRD4—conduct disorder	7.27e-05	0.000726	CbGpPWpGaD
Paliperidone—ADRA2C—GPCR ligand binding—HTR2A—conduct disorder	7.08e-05	0.000707	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—CGA—conduct disorder	7.06e-05	0.000705	CbGpPWpGaD
Paliperidone—ADRA2C—Metabolism—CGA—conduct disorder	7.03e-05	0.000701	CbGpPWpGaD
Paliperidone—ADRA1B—GPCR ligand binding—HTR2A—conduct disorder	6.97e-05	0.000696	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—CGA—conduct disorder	6.97e-05	0.000696	CbGpPWpGaD
Paliperidone—DRD1—Signaling by GPCR—DRD4—conduct disorder	6.7e-05	0.000668	CbGpPWpGaD
Paliperidone—DRD3—Signaling by GPCR—DRD4—conduct disorder	6.61e-05	0.000659	CbGpPWpGaD
Paliperidone—ADRA2B—GPCR downstream signaling—DRD4—conduct disorder	6.57e-05	0.000656	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—WASF1—conduct disorder	6.53e-05	0.000651	CbGpPWpGaD
Paliperidone—DRD2—GPCR ligand binding—HTR2A—conduct disorder	6.43e-05	0.000641	CbGpPWpGaD
Paliperidone—CYP3A4—Biological oxidations—COMT—conduct disorder	6.42e-05	0.000641	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—WASF1—conduct disorder	6.39e-05	0.000638	CbGpPWpGaD
Paliperidone—CYP3A4—Biological oxidations—MAOA—conduct disorder	6.37e-05	0.000636	CbGpPWpGaD
Paliperidone—DRD2—Circadian rythm related genes—EP300—conduct disorder	6.37e-05	0.000636	CbGpPWpGaD
Paliperidone—HTR1A—GPCR downstream signaling—DRD4—conduct disorder	6.34e-05	0.000633	CbGpPWpGaD
Paliperidone—CYP3A4—Metapathway biotransformation—COMT—conduct disorder	6.33e-05	0.000632	CbGpPWpGaD
Paliperidone—HRH1—GPCR ligand binding—HTR2A—conduct disorder	6.31e-05	0.00063	CbGpPWpGaD
Paliperidone—HTR2C—GPCR downstream signaling—DRD4—conduct disorder	6.31e-05	0.00063	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—CGA—conduct disorder	6.29e-05	0.000628	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—WASF1—conduct disorder	6.29e-05	0.000628	CbGpPWpGaD
Paliperidone—ADRA1A—GPCR ligand binding—HTR2A—conduct disorder	6.19e-05	0.000618	CbGpPWpGaD
Paliperidone—ADRA2C—GPCR downstream signaling—DRD4—conduct disorder	6.13e-05	0.000612	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—CGA—conduct disorder	6.07e-05	0.000606	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—CGA—conduct disorder	6.04e-05	0.000603	CbGpPWpGaD
Paliperidone—ADRA1B—GPCR downstream signaling—DRD4—conduct disorder	6.04e-05	0.000603	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling by GPCR—DRD4—conduct disorder	5.96e-05	0.000595	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—CGA—conduct disorder	5.88e-05	0.000587	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—CGA—conduct disorder	5.78e-05	0.000577	CbGpPWpGaD
Paliperidone—HTR1A—Signaling by GPCR—DRD4—conduct disorder	5.76e-05	0.000575	CbGpPWpGaD
Paliperidone—ADRA2A—GPCR ligand binding—HTR2A—conduct disorder	5.75e-05	0.000574	CbGpPWpGaD
Paliperidone—HTR2C—Signaling by GPCR—DRD4—conduct disorder	5.73e-05	0.000572	CbGpPWpGaD
Paliperidone—ADRA2A—Metabolism—CGA—conduct disorder	5.71e-05	0.00057	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—WASF1—conduct disorder	5.66e-05	0.000565	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—WASF1—conduct disorder	5.58e-05	0.000557	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling by GPCR—DRD4—conduct disorder	5.57e-05	0.000556	CbGpPWpGaD
Paliperidone—DRD2—GPCR downstream signaling—DRD4—conduct disorder	5.57e-05	0.000556	CbGpPWpGaD
Paliperidone—HTR1D—GPCR downstream signaling—HTR2A—conduct disorder	5.55e-05	0.000554	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling by GPCR—DRD4—conduct disorder	5.48e-05	0.000547	CbGpPWpGaD
Paliperidone—HTR2A—GPCR downstream signaling—DRD4—conduct disorder	5.48e-05	0.000547	CbGpPWpGaD
Paliperidone—HRH1—GPCR downstream signaling—DRD4—conduct disorder	5.47e-05	0.000546	CbGpPWpGaD
Paliperidone—HTR1B—GPCR downstream signaling—HTR2A—conduct disorder	5.43e-05	0.000542	CbGpPWpGaD
Paliperidone—ADRA1A—GPCR downstream signaling—DRD4—conduct disorder	5.36e-05	0.000535	CbGpPWpGaD
Paliperidone—DRD4—GPCR downstream signaling—HTR2A—conduct disorder	5.34e-05	0.000533	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—CGA—conduct disorder	5.33e-05	0.000532	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—CGA—conduct disorder	5.25e-05	0.000524	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—CGA—conduct disorder	5.24e-05	0.000523	CbGpPWpGaD
Paliperidone—CYP3A5—Metabolism—CGA—conduct disorder	5.23e-05	0.000522	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—CGA—conduct disorder	5.14e-05	0.000513	CbGpPWpGaD
Paliperidone—DRD2—Signaling by GPCR—DRD4—conduct disorder	5.05e-05	0.000505	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—WASF1—conduct disorder	5.04e-05	0.000503	CbGpPWpGaD
Paliperidone—HTR1D—Signaling by GPCR—HTR2A—conduct disorder	5.04e-05	0.000503	CbGpPWpGaD
Paliperidone—ADRA2A—GPCR downstream signaling—DRD4—conduct disorder	4.98e-05	0.000497	CbGpPWpGaD
Paliperidone—HTR2A—Signaling by GPCR—DRD4—conduct disorder	4.97e-05	0.000496	CbGpPWpGaD
Paliperidone—HRH1—Signaling by GPCR—DRD4—conduct disorder	4.96e-05	0.000495	CbGpPWpGaD
Paliperidone—HTR1B—Signaling by GPCR—HTR2A—conduct disorder	4.93e-05	0.000492	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling by GPCR—DRD4—conduct disorder	4.87e-05	0.000486	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—WASF1—conduct disorder	4.87e-05	0.000486	CbGpPWpGaD
Paliperidone—DRD4—Signaling by GPCR—HTR2A—conduct disorder	4.85e-05	0.000484	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—WASF1—conduct disorder	4.84e-05	0.000483	CbGpPWpGaD
Paliperidone—DRD1—GPCR downstream signaling—HTR2A—conduct disorder	4.81e-05	0.00048	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—CGA—conduct disorder	4.77e-05	0.000476	CbGpPWpGaD
Paliperidone—DRD3—GPCR downstream signaling—HTR2A—conduct disorder	4.75e-05	0.000474	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—WASF1—conduct disorder	4.71e-05	0.00047	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—WASF1—conduct disorder	4.64e-05	0.000463	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—DRD4—conduct disorder	4.56e-05	0.000455	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling by GPCR—DRD4—conduct disorder	4.53e-05	0.000452	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—DRD4—conduct disorder	4.46e-05	0.000446	CbGpPWpGaD
Paliperidone—DRD1—Signaling by GPCR—HTR2A—conduct disorder	4.37e-05	0.000436	CbGpPWpGaD
Paliperidone—DRD3—Signaling by GPCR—HTR2A—conduct disorder	4.31e-05	0.00043	CbGpPWpGaD
Paliperidone—ADRA2B—GPCR downstream signaling—HTR2A—conduct disorder	4.29e-05	0.000428	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—WASF1—conduct disorder	4.27e-05	0.000427	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—WASF1—conduct disorder	4.2e-05	0.00042	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—WASF1—conduct disorder	4.2e-05	0.000419	CbGpPWpGaD
Paliperidone—HTR1A—GPCR downstream signaling—HTR2A—conduct disorder	4.14e-05	0.000413	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—WASF1—conduct disorder	4.12e-05	0.000411	CbGpPWpGaD
Paliperidone—HTR2C—GPCR downstream signaling—HTR2A—conduct disorder	4.12e-05	0.000411	CbGpPWpGaD
Paliperidone—ADRA2C—GPCR downstream signaling—HTR2A—conduct disorder	4e-05	0.0004	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—DRD4—conduct disorder	3.96e-05	0.000395	CbGpPWpGaD
Paliperidone—ADRA1B—GPCR downstream signaling—HTR2A—conduct disorder	3.94e-05	0.000393	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—DRD4—conduct disorder	3.9e-05	0.00039	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling by GPCR—HTR2A—conduct disorder	3.89e-05	0.000388	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—WASF1—conduct disorder	3.83e-05	0.000382	CbGpPWpGaD
Paliperidone—HTR1A—Signaling by GPCR—HTR2A—conduct disorder	3.76e-05	0.000375	CbGpPWpGaD
Paliperidone—HTR2C—Signaling by GPCR—HTR2A—conduct disorder	3.74e-05	0.000373	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—CGA—conduct disorder	3.72e-05	0.000371	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling by GPCR—HTR2A—conduct disorder	3.63e-05	0.000363	CbGpPWpGaD
Paliperidone—DRD2—GPCR downstream signaling—HTR2A—conduct disorder	3.63e-05	0.000363	CbGpPWpGaD
Paliperidone—ADRA2B—Hemostasis—EP300—conduct disorder	3.59e-05	0.000359	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling by GPCR—HTR2A—conduct disorder	3.58e-05	0.000357	CbGpPWpGaD
Paliperidone—HRH1—GPCR downstream signaling—HTR2A—conduct disorder	3.57e-05	0.000356	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—DRD4—conduct disorder	3.52e-05	0.000352	CbGpPWpGaD
Paliperidone—ADRA1A—GPCR downstream signaling—HTR2A—conduct disorder	3.5e-05	0.000349	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—DRD4—conduct disorder	3.4e-05	0.000339	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—DRD4—conduct disorder	3.38e-05	0.000338	CbGpPWpGaD
Paliperidone—ADRA2C—Hemostasis—EP300—conduct disorder	3.36e-05	0.000335	CbGpPWpGaD
Paliperidone—DRD2—Signaling by GPCR—HTR2A—conduct disorder	3.3e-05	0.000329	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—DRD4—conduct disorder	3.29e-05	0.000328	CbGpPWpGaD
Paliperidone—ADRA2A—GPCR downstream signaling—HTR2A—conduct disorder	3.25e-05	0.000325	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—DRD4—conduct disorder	3.24e-05	0.000323	CbGpPWpGaD
Paliperidone—HRH1—Signaling by GPCR—HTR2A—conduct disorder	3.24e-05	0.000323	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling by GPCR—HTR2A—conduct disorder	3.18e-05	0.000317	CbGpPWpGaD
Paliperidone—ADRA2C—Metabolism—COMT—conduct disorder	3.17e-05	0.000317	CbGpPWpGaD
Paliperidone—ADRA2C—Metabolism—MAOA—conduct disorder	3.15e-05	0.000314	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—DRD4—conduct disorder	2.99e-05	0.000298	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—HTR2A—conduct disorder	2.97e-05	0.000297	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling by GPCR—HTR2A—conduct disorder	2.95e-05	0.000295	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—DRD4—conduct disorder	2.94e-05	0.000293	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—DRD4—conduct disorder	2.93e-05	0.000293	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—HTR2A—conduct disorder	2.91e-05	0.000291	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—DRD4—conduct disorder	2.88e-05	0.000287	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—HTR2A—conduct disorder	2.87e-05	0.000286	CbGpPWpGaD
Paliperidone—ADRA2A—Hemostasis—EP300—conduct disorder	2.73e-05	0.000272	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—DRD4—conduct disorder	2.67e-05	0.000267	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—HTR2A—conduct disorder	2.58e-05	0.000258	CbGpPWpGaD
Paliperidone—ADRA2A—Metabolism—COMT—conduct disorder	2.58e-05	0.000257	CbGpPWpGaD
Paliperidone—ADRA2A—Metabolism—MAOA—conduct disorder	2.56e-05	0.000255	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—HTR2A—conduct disorder	2.55e-05	0.000254	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—CGA—conduct disorder	2.43e-05	0.000243	CbGpPWpGaD
Paliperidone—CYP3A5—Metabolism—COMT—conduct disorder	2.36e-05	0.000236	CbGpPWpGaD
Paliperidone—CYP3A5—Metabolism—MAOA—conduct disorder	2.34e-05	0.000234	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—HTR2A—conduct disorder	2.3e-05	0.000229	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—HTR2A—conduct disorder	2.22e-05	0.000221	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—HTR2A—conduct disorder	2.21e-05	0.00022	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—HTR2A—conduct disorder	2.15e-05	0.000214	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—HTR2A—conduct disorder	2.11e-05	0.000211	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—HTR2A—conduct disorder	1.95e-05	0.000194	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—HTR2A—conduct disorder	1.91e-05	0.000191	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—HTR2A—conduct disorder	1.88e-05	0.000187	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—HTR2A—conduct disorder	1.74e-05	0.000174	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—COMT—conduct disorder	1.68e-05	0.000168	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—MAOA—conduct disorder	1.67e-05	0.000166	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—EP300—conduct disorder	1.58e-05	0.000157	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—EP300—conduct disorder	1.54e-05	0.000154	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—EP300—conduct disorder	1.52e-05	0.000152	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—EP300—conduct disorder	1.37e-05	0.000136	CbGpPWpGaD
Paliperidone—ADRA2C—Metabolism—EP300—conduct disorder	1.36e-05	0.000136	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—EP300—conduct disorder	1.35e-05	0.000135	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—EP300—conduct disorder	1.22e-05	0.000122	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—EP300—conduct disorder	1.18e-05	0.000117	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—EP300—conduct disorder	1.17e-05	0.000117	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—EP300—conduct disorder	1.14e-05	0.000114	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—EP300—conduct disorder	1.12e-05	0.000112	CbGpPWpGaD
Paliperidone—ADRA2A—Metabolism—EP300—conduct disorder	1.11e-05	0.00011	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—COMT—conduct disorder	1.1e-05	0.00011	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—MAOA—conduct disorder	1.09e-05	0.000109	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—EP300—conduct disorder	1.03e-05	0.000103	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—EP300—conduct disorder	1.02e-05	0.000101	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—EP300—conduct disorder	1.01e-05	0.000101	CbGpPWpGaD
Paliperidone—CYP3A5—Metabolism—EP300—conduct disorder	1.01e-05	0.000101	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—EP300—conduct disorder	9.94e-06	9.93e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—EP300—conduct disorder	9.24e-06	9.22e-05	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—EP300—conduct disorder	7.2e-06	7.19e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—EP300—conduct disorder	4.71e-06	4.7e-05	CbGpPWpGaD
